156 related articles for article (PubMed ID: 22859944)
1. A meta-analysis of interleukin-10 -592 promoter polymorphism associated with gastric cancer risk.
Xue H; Wang YC; Lin B; An J; Chen L; Chen J; Fang JY
PLoS One; 2012; 7(7):e39868. PubMed ID: 22859944
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10-819 promoter polymorphism in association with gastric cancer risk.
Xue H; Lin B; An J; Zhu Y; Huang G
BMC Cancer; 2012 Mar; 12():102. PubMed ID: 22436502
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of interleukin-8 -251 promoter polymorphism associated with gastric cancer risk.
Xue H; Liu J; Lin B; Wang Z; Sun J; Huang G
PLoS One; 2012; 7(1):e28083. PubMed ID: 22279522
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of interleukin-10-1082 promoter polymorphism associated with gastric cancer risk.
Ni P; Xu H; Xue H; Lin B; Lu Y
DNA Cell Biol; 2012 Apr; 31(4):582-91. PubMed ID: 22335769
[TBL] [Abstract][Full Text] [Related]
5. The effect of XPD/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.
Xue H; Lu Y; Lin B; Chen J; Tang F; Huang G
PLoS One; 2012; 7(9):e43431. PubMed ID: 23028453
[TBL] [Abstract][Full Text] [Related]
6. Effects of the interleukin-1β-511 C/T gene polymorphism on the risk of gastric cancer in the context of the relationship between race and H. pylori infection: a meta-analysis of 20,000 subjects.
Park MJ; Hyun MH; Yang JP; Yoon JM; Park S
Mol Biol Rep; 2015 Jan; 42(1):119-34. PubMed ID: 25258120
[TBL] [Abstract][Full Text] [Related]
7. Roles of Cyclooxygenase-2 gene -765G > C (rs20417) and -1195G > A (rs689466) polymorphisms in gastric cancer: A systematic review and meta-analysis.
Luo MX; Long BB; Li F; Zhang C; Pan MT; Huang YQ; Chen B
Gene; 2019 Feb; 685():125-135. PubMed ID: 30391440
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-1B 31 C>T polymorphism combined with Helicobacter pylori-modified gastric cancer susceptibility: evidence from 37 studies.
Ying HY; Yu BW; Yang Z; Yang SS; Bo LH; Shan XY; Wang HJ; Zhu YJ; Wu XS
J Cell Mol Med; 2016 Mar; 20(3):526-36. PubMed ID: 26805397
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of CDH1 C-160A genetic polymorphism and gastric cancer risk.
Cui Y; Xue H; Lin B; Ni P; Fang JY
DNA Cell Biol; 2011 Nov; 30(11):937-45. PubMed ID: 21612411
[TBL] [Abstract][Full Text] [Related]
10. Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer.
Ma LC; Tian XY; Gao F; Dong WJ; Dang T; Jia YB
BMC Gastroenterol; 2020 May; 20(1):155. PubMed ID: 32423384
[TBL] [Abstract][Full Text] [Related]
11. The effect of CYP1A1 and CYP1A2 polymorphisms on gastric cancer risk among different ethnicities: a systematic review and meta-analysis.
Xue H; Lu Y; Xue Z; Lin B; Chen J; Tang F; Huang G
Tumour Biol; 2014 May; 35(5):4741-56. PubMed ID: 24443269
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis.
Xue H; Lin B; Ni P; Xu H; Huang G
J Gastroenterol Hepatol; 2010 Oct; 25(10):1604-17. PubMed ID: 20880168
[TBL] [Abstract][Full Text] [Related]
13. Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China.
Zeng X; Li Y; Liu T; Zhang J
Mol Cell Biochem; 2012 Mar; 362(1-2):241-8. PubMed ID: 22081333
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan.
Taguchi A; Ohmiya N; Shirai K; Mabuchi N; Itoh A; Hirooka Y; Niwa Y; Goto H
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2487-93. PubMed ID: 16284368
[TBL] [Abstract][Full Text] [Related]
15. Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes.
Sicinschi LA; Lopez-Carrillo L; Camargo MC; Correa P; Sierra RA; Henry RR; Chen J; Zabaleta J; Piazuelo MB; Schneider BG
Int J Cancer; 2006 Feb; 118(3):649-57. PubMed ID: 16114018
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17A gene polymorphism is associated with susceptibility to gastric cancer.
Hou C; Yang F
Int J Clin Exp Pathol; 2015; 8(6):7378-84. PubMed ID: 26261639
[TBL] [Abstract][Full Text] [Related]
17. Association of IL-10-1082 promoter polymorphism with susceptibility to gastric cancer: evidence from 22 case-control studies.
Pan F; Tian J; Pan YY; Zhang Y
Mol Biol Rep; 2012 Jun; 39(6):7143-54. PubMed ID: 22311038
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-8-251A/T polymorphism and Helicobacter pylori infection influence risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of China.
Zhang L; Du C; Guo X; Yuan L; Niu W; Yu W; Er L; Wang S
Mol Biol Rep; 2010 Dec; 37(8):3983-9. PubMed ID: 20300863
[TBL] [Abstract][Full Text] [Related]
19. IL-17 rs2275913 genetic variation contributes to the development of gastric cancer in a Chinese population.
Xu BL; Li YT; Dong SX; Qi J; Feng HM; Zi L; Yang DY
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323118
[TBL] [Abstract][Full Text] [Related]
20. Combination of Helicobacter pylori infection and the interleukin 8 -251 T > A polymorphism, but not the mannose-binding lectin 2 codon 54 G > A polymorphism, might be a risk factor of gastric cancer.
Chang YW; Oh CH; Kim JW; Lee JW; Park MJ; Shim JJ; Lee CK; Jang JY; Dong SH; Kim HJ; Kim SS; Kim BH
BMC Cancer; 2017 May; 17(1):388. PubMed ID: 28558668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
